Genetic markers in a multi-ethnic sample for childhood acute lymphoblastic leukemia risk

Leukemia and Lymphoma

Volumn 56, Issue 1, 2015, Pages 169-174

  Kennedy, Amy E ^a,c   Kamdar, Kala Y ^b   Lupo, Philip J ^b   Okcu, M Fatih ^b   Scheurer, Michael E ^b   Dorak, M Tevfik ^a,d  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d LIVERPOOL HOPE UNIVERSITY   (United Kingdom)

Author keywords

Childhood acute lymphoblastic leukemia; Genetic associations; Genetic predisposition to disease

Indexed keywords

GENETIC MARKER; HLA ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; CASE CONTROL STUDY; CHILD; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; PRESCHOOL CHILD; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC LOCI; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HLA ANTIGENS; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84922371201     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.910662     Document Type: Article

References (58)

1. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-236.
2. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006; 6: 193-203.
3. Mody R, Li S, Dover DC, et al. Twenty-f ve-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood 2008; 111: 5515-5523.
4. Sherborne AL, Hemminki K, Kumar R, et al. Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia. Haematologica 2011; 96: 1049-1054.
5. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2010. Bethesda, MD: National Cancer Institute; 2013.
6. McNeil DE, Cote TR, Clegg L, et al. SEER update of incidence and trends in pediatric malignancies: acute lymphoblastic leukemia. Med Pediatr Oncol 2002;39:554-557; discussion 552-553.
7. Matasar MJ, Ritchie EK, Consedine N, et al. Incidence rates of the major leukemia subtypes among US Hispanics, Blacks, and non-Hispanic Whites. Leuk Lymphoma 2006; 47: 2365-2370.
8. Xu H, Cheng C, Devidas M, et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 2012;30:751-757.
9. Swinney RM, Beuten J, Collier AB 3rd, et al. Polymorphisms in CYP1A1 and ethnic-specif c susceptibility to acute lymphoblastic leukemia in children. Cancer Epidemiol Biomarkers Prev 2011; 20: 1537-1542.
10. Birch JM. Genes and cancer. Arch Dis Child 1999; 80: 1-3.
11. Pui CH. Childhood leukemias. N Engl J Med 1995; 332: 1618-1630.
12. Belson M, Kingsley B, Holmes A. Risk factors for acute leukemia in children: a review. Environ Health Perspect 2007; 115: 138-145.
13. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;371:1030-1043.
14. Feller M, Adam M, Zwahlen M, et al. Family characteristics as risk factors for childhood acute lymphoblastic leukemia: a population-based case-control study. PLoS One 2010; 5. pii:e13156
15. Greaves MF. Aetiology of acute leukaemia. Lancet 1997;349: 344-349.
16. Hjalgrim LL, Westergaard T, Rostgaard K, et al. Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. Am J Epidemiol 2003;158:724-735.
17. Hjalgrim LL, Rostgaard K, Hjalgrim H, et al. Birth weight and risk for childhood leukemia in Denmark, Sweden, Norway, and Iceland. J Natl Cancer Inst 2004;96:1549-1556.
18. Caughey RW, Michels KB. Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer 2009;124:2658-2670.
19. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009; 41: 1006-1010.
20. Trevino LR, Yang W, French D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009;41:1001-1005.
21. Orsi L, Rudant J, Bonaventure A, et al. Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia 2012;26:2561-2564.
22. Xu H, Yang W, Perez-Andreu V, et al. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst 2013;105:733-742.
23. Kennedy AE, Singh SK, Dorak MT. Re: genome-wide association study of classical hodgkin lymphoma and epstein-barr virus status-defned subgroups. J Natl Cancer Inst 2012;104:884-885.
24. Dorak MT, Lawson T, Machulla HK, et al. Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia. Blood 1999;94:694-700.
25. Dorak MT, Oguz FS, Yalman N, et al. A male-specif c increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. Leuk Res 2002;26:651-656.
26. Urayama KY, Jarrett RF, Hjalgrim H, et al. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defned subgroups. J Natl Cancer Inst 2012;104:240-253.
27. Lan Q, Hsiung CA, Matsuo K, et al. Genome-wide association analysis identif es new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet 2012;44:1330-1335.
28. Plenge RM, Cotsapas C, Davies L, et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007;39:1477-1482.
29. Li X, Ampleford EJ, Howard TD, et al. Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. J Allergy Clin Immunol 2012;130:861-868 e7.
30. Asano K, Matsushita T, Umeno J, et al. Agenome-wide association study identif es three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet 2009; 41: 1325-1329.
31. Juyal G, Prasad P, Senapati S, et al. An investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians. PLoS One 2011; 6: e16565.
32. Silverberg MS, Cho JH, Rioux JD, et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 2009;41:216-220.
33. Conde L, Halperin E, Akers NK, et al. Genome-wide association study of follicular lymphoma identif es a risk locus at 6p21.32. Nat Genet 2010;42:661-664.
34. Smedby KE, Foo JN, Skibola CF, et al. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with dif use large B-cell lymphoma. PLoS Genet 2011;7:e1001378.
35. Enoch MA, Shen PH, Xu K, Hodgkinson C, Goldman D. Using ancestry-informative markers to def ne populations and detect population stratifcation. J Psychopharmacol 2006;20:19-26.
36. Ziv E, John EM, Choudhry S, et al. Genetic ancestry and risk factors for breast cancer among Latinas in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev 2006;15:1878-1885.
37. Lee YL, Teitelbaum S, Wolf MS, et al. Comparing genetic ancestry and self-reported race/ethnicity in a multiethnic population in New York City. J Genet 2010;89:417-423.
38. Healy J, Richer C, Bourgey M, et al. Replication analysis conf rms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica 2010; 95: 1608-1611.
39. Prasad RB, Hosking FJ, Vijayakrishnan J, et al. Verif cation of the susceptibility loci on 7p12.2, 10q21.2 and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 2010;115: 1765-1767.
40. Chokkalingam AP, Hsu LI, Metayer C, et al. Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics. Cancer Causes Control 2013;24:1789-1795.
41. Yang JJ, Cheng C, Devidas M, et al. Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet 2011; 43: 237-241.
42. Lautner-Csorba O, Gezsi A, Semsei AF, et al. Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance. BMC Med Genomics 2012;5:42.
43. Mullighan CG, Downing JR. Genome-wide prof ling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia 2009;23:1209-1218.
44. Nakanishi K, Shima Y. Capture of type 1 diabetes-susceptible HLA DR-DQ haplotypes in Japanese subjects using a tag single nucleotide polymorphism. Diabetes Care 2010; 33: 162-164.
45. Seremetis S, Cuttner J, Winchester R. Def nition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope. J Clin Invest 1985;76:1391-1397.
46. Oguz FS, Kalayoglu S, Diler AS, et al. HLA system af ects the age-at-onset in chronic myeloid leukemia. Am J Hematol 2003; 73: 256-262.
47. Machulla HK, Muller LP, Schaaf A, et al. Association of chronic lymphocytic leukemia with specif c alleles of the HLA-DR4:DR53:DQ8 haplotype in German patients. Int J Cancer 2001;92:203-207.
48. Dyer PA, Ridway JC, Flanagan NG. HLA-A, B and DR antigens in chronic lymphocytic leukaemia. Dis Markers 1986; 4: 231-237.
49. Dorak MT, Machulla HK, Hentschel M, et al. Inf uence of the major histocompatibility complex on age at onset of chronic lymphoid leukaemia. Int J Cancer 1996;65:134-139.
50. Dorak MT, Owen G, Galbraith I, et al. Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia. Leukemia 1995;9:875-878.
51. Dorak MT, Chalmers EA, Gafney D, et al. Human major histocompatibility complex contains several leukemia susceptibility genes. Leuk Lymphoma 1994; 12: 211-222.
52. Latiano A, Palmieri O, Latiano T, et al. Investigation of multiple susceptibility loci for inf ammatory bowel disease in an Italian cohort of patients. PLoS One 2011;6:e22688.
53. Satta Y, Mayer WE, Klein J. HLA-DRB intron 1 sequences: implications for the evolution of HLA-DRB genes and haplotypes. Hum Immunol 1996;51:1-12.
54. Zheng G, Joo J, Lin JP, et al. Robust ranks of true associations in genome-wide case-control association studies. BMC Proc 2007; 1(Suppl. 1):S165.
55. Lettre G, Lange C, Hirschhorn JN. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet Epidemiol 2007;31:358-562.
56. Freidlin B, Zheng G, Li Z, et al. Trend tests for case-control studies of genetic markers: power, sample size and robustness. Hum Hered 2002;53:146-152.
57. Mez JB, Cole JW, Howard TD, et al. Evaluation of self-reported ethnicity in a case-control population: the stroke prevention in young women study. BMC Res Notes 2009;2:260.
58. Lopez-Lopez E, Gutierrez-Camino A, Martin-Guerrero I, et al. Re: Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst 2013;105:1512.